LeaderPortfolio
Fangyi
Liu Fangyi
Rank #1882
CHINAHealthcareMedical equipment

Liu Fangyi

Net Worth
$2.187B
-2.21% (24h)
Liu Fangyi is a prominent Chinese entrepreneur and the founder and chairman of INTCO Medical Technology Co., Ltd. His source of wealth stems from his leadership in the medical equipment industry, specializing in disposable medical consumables like gloves, wheelchairs, and gauze. Liu's career began with studies and trade in the United States from 1989 to 1999. Returning to China in 2000, he spearheaded joint ventures and contributed to establishing two publicly listed companies. In 2009, he founded INTCO Medical, which went public on the Shenzhen Stock Exchange in 2017. His innovative approach to intelligent manufacturing has positioned INTCO Medical as a global leader, earning him several awards, and a net worth of $2.5 Billion.

How to read Liu Fangyi's profile

Public net-worth figures are estimates. They combine observable inputs—typically listed equity, disclosed transactions, and market prices—with editorial judgment where filings are incomplete (for example, private holdings, debt, or cross-holdings). For Liu Fangyi, we anchor the narrative to Medical equipment and Medical equipment, then update the headline number as markets move. The chart on this page is meant to show trajectory, not a certified balance sheet.

When you see $2.187B alongside global rank #1882, interpret it as our best synthesis of widely cited ownership and price signals—not a claim about cash on hand. Estimates can diverge from other publishers because of different treatment of options, trusts, charitable vehicles, or illiquid assets. We document the general approach in methodology and welcome corrections via corrections.

Country (CHINA) and career milestones on this page are curated for reader context; they should be verified against primary sources when used for research. Editorial metadata for this profile is refreshed on a rolling basis, with deeper audits at least annually (last noted cycle: 2026).

Looking for depth? When available, the dossier and timeline sections below add long-form context beyond the headline number—prioritize those modules when evaluating claims about strategy, controversies, or philanthropic commitments.

The Full Dossier

Early Life

Liu Fangyi, also known as Frank Liu, was born in China. From 1989 to 1999, he studied and engaged in trade activities in the United States, gaining experience in global markets. He returned to China in 2000 to pursue joint ventures.

Rise to Success

In 2009, Liu founded the predecessor to INTCO Medical in Zibo, China, focusing on intelligent manufacturing within the medical sector. This led to the company's successful listing on the Shenzhen Stock Exchange in 2017. Under Liu's guidance, INTCO Medical expanded into a global high-tech enterprise focused on medical devices and consumables. He has since become a key player in China's healthcare manufacturing sector. INTCO Medical experienced significant growth during the COVID-19 pandemic due to increased demand for medical gloves.

Key Business Strategies

Liu's primary business venture is INTCO Medical Technology (SZSE: 300677), a major supplier of disposable medical gloves, wheelchairs, and gauze. He has focused on R&D innovation and efficient supply chains, contributing to the company's expansion and success. He also founded Intco Recycling, a separate company focused on recycling plastic foam.

Philanthropy

In 2016, Liu and his wife Wang Ping established the Myhome Community Volunteer Philanthropic Foundation, donating $11 million to help senior citizens volunteer for community services. Liu's company, INTCO Medical, also integrates social responsibility into its development strategy, supporting education, rural revitalization, and other public welfare projects.

Career Timeline

2025

Pharmaceutical Industry Outstanding Contribution Award

Awarded for his contributions to the pharmaceutical industry.

2017

INTCO Medical IPO

Led INTCO Medical to a successful IPO on the Shenzhen Stock Exchange.

2009

Founded INTCO Medical

Founded the predecessor to INTCO Medical in Zibo, China.

Philanthropic Impact

Community Service$11M

Myhome Community Volunteer Philanthropic Foundation

Pledged $11 million to the Myhome Community Volunteer Philanthropic Foundation in China's Hubei Province.

Key Business Ventures & Holdings

CompanyStakeValue
INTCO Medical Technology Co., Ltd.12.43%$0.371M

Net Worth History

In-Depth Analysis

Early Life

Liu Fangyi, also known as Frank Liu, was born in China. From 1989 to 1999, he studied and engaged in trade activities in the United States, gaining experience in global markets. He returned to China in 2000 to pursue joint ventures.

Rise to Success

In 2009, Liu founded the predecessor to INTCO Medical in Zibo, China, focusing on intelligent manufacturing within the medical sector. This led to the company's successful listing on the Shenzhen Stock Exchange in 2017. Under Liu's guidance, INTCO Medical expanded into a global high-tech enterprise focused on medical devices and consumables. He has since become a key player in China's healthcare manufacturing sector. INTCO Medical experienced significant growth during the COVID-19 pandemic due to increased demand for medical gloves.

Key Business Strategies

Liu's primary business venture is INTCO Medical Technology (SZSE: 300677), a major supplier of disposable medical gloves, wheelchairs, and gauze. He has focused on R&D innovation and efficient supply chains, contributing to the company's expansion and success. He also founded Intco Recycling, a separate company focused on recycling plastic foam.

Philanthropy

In 2016, Liu and his wife Wang Ping established the Myhome Community Volunteer Philanthropic Foundation, donating $11 million to help senior citizens volunteer for community services. Liu's company, INTCO Medical, also integrates social responsibility into its development strategy, supporting education, rural revitalization, and other public welfare projects.

Data Sources & Methodology

Figures for Liu Fangyi are synthesized from the sources below and cross-checked against our net worth methodology. Estimates may lag market moves; see corrections to report discrepancies.